Get the Weekly Intelligence Brief — top committee picks every Sunday.

ADPT vs GMED

Adaptive Biotechnologies Corporation vs Globus Medical — AI-powered side-by-side comparison
ADPT
Adaptive Biotechnologies Corporation
59
Watch
VS
GMED
Globus Medical
71
Buy
MetricADPTGMED
AI Score 59 71
Price $25.39 $85.12
P/E Ratio -62.32× 21.45×
ROE -27.2% 11.8%
Revenue Growth YoY
Gross Margin 75.4% 68.5%
Debt / Equity 2.87× 0.02×
Dividend Yield 0.0% 0.0%
RSI (14) 67.3 75.9
Beta 2.088 0.954
Expected Upside +0.1%

AI Committee View

Current Innellis committee reasoning for ADPT versus GMED.
GMED leads by 12 points.

GMED scores 71/100 (Buy) versus ADPT at 59/100 (Watch).

ADPT Committee View
50% agreement
6 analysts

The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 50.1% yoy -- genuine top-line momentum. Value Analyst remains cautious — price-to-book of 11.3x prices in significant intangible value. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Revenue growing 50.1% YoY -- genuine top-line momentum — Growth
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • Price-to-book of 11.3x prices in significant intangible value — Value
  • ROE of only -32.6% -- cheap may mean cheap for a reason — Value
  • Weekly RSI at 85 -- overbought on the larger timeframe too — Technical
GMED Committee View
75% agreement
4 analysts

The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is rsi at 76 is in overbought territory. The committee is constructive but not yet at full conviction.

Bull Case
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • RSI at 76 is in overbought territory — Technical
  • Price trading above the upper Bollinger Band -- stretched — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ADPT Full Analysis GMED Full Analysis